MedPath
NMPA Approval

Methotrexate Injection

国药准字HJ20090596

November 7, 2024

H20090596

Drug Information

甲氨蝶呤注射液

美素生

注射剂

20ml:0.5g

化学药品

November 7, 2024

November 6, 2029

Company Information

Applicant Company

Level 17 151 Clarence Street Sydney NSW 2000 AUSTRALIA

Manufacturing Company

1-5 7-23 and 25-39 Lexia Place MULGRAVE VIC 3170 Australia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲氨蝶呤注射液 - NMPA 批准文号 | MedPath